Even though we have validated the downregulation of TGFBI and NFKB2 by ectopic VHL overexpression in RCC4 and RCC10 (Figure 5M), future studies should validate the VHL candidate substrates across more VHL-defective and VHL-intact ccRCC cell lines. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.